课题基金 / 基金详情

NSF/FDA/SIR: Evaluating cellular integrity as a function of bioprinter nozzle geometry

NSF/FDA/SIR: Evaluating cellular integrity as a function of bioprinter nozzle geometry
NSF/FDA/SIR:根据生物打印机喷嘴几何形状评估细胞完整性
批准号:
1935836
负责人:
Brad Berron
金额:
$10.67万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2021-08-31

项目摘要

项目成果

Brad Berron的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Bioprinting" is an approach to assemble individual living cells to form tissue like skin or muscle, much like 3-D printing with metal or plastic to form machine parts. This method promises to revolutionize fabrication of tissue replacements or tissue models for drug testing. A limitation of bioprinting is that individual cells are fragile and may be damaged by being squirted through a narrow tube called a capillary through a small opening. The project proposes to measure damage to the cell membrane, internal skeleton, and DNA depending on the properties of the printing capillary. The applicants propose to address an important issue in "bioprinting", which is like 3D printing to assemble cells into tissue like skin or muscle. The issue is that the shear forces in the narrow capillary in the print head can damage the cell membrane, cytoskeleton, and DNA in the nucleus; slowing the liquid flow in the capillary to reduce the shear force may result in an unacceptable reduction in print speed. The applicants propose to determine the effects of shear time and changes in capillary properties on the cell damage.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF/FDA SIR: Assurance of Cellular Function in High-Shear Three-Dimensional Bioprinting
CAREER: Artificial Cell Membranes for Ultra-Pure, High Throughput Cellular Isolation
Coatings for Light-Actuated Nanoscale Topography
国内基金
海外基金
FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
  • 批准号:
    82373165
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李爱民
  • 依托单位:
多维互质结构FDA雷达稀疏空时距自适应处理研究
  • 批准号:
    61771317
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2017
  • 负责人:
    阳召成
  • 依托单位:
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
  • 批准号:
    81573740
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2015
  • 负责人:
    宋殿荣
  • 依托单位: